David J. Mauro
Chief Medical Officer, Advaxis.
Companies
- Recursion PharmaceuticalsChief Medical Officer Jun 7, 2023 to Nov 19, 20241
- Codiak BioSciences, Inc.Chief Medical Officer May 4, 2022 to Jan 26, 20232
- Prelude Therapeutics IncChief Medical Officer Sep 24, 2020 to Oct 6, 20213
- AdvaxisChief Medical Officer Oct 21, 2014 to Jan 4, 20164
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Recursion Pharmaceuticals RXRX225,429 shares5$819.4K at $3.63Nov 15, 2024- Prelude Therapeutics Inc PRLD0 shares6Oct 5, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 15, 2024Shares withheld for tax 4,187 shares at $6.18 of Recursion Pharmaceuticals5
- Aug 15, 2024Shares withheld for tax 14,146 shares at $6.69 of Recursion Pharmaceuticals7
- May 15, 2024Shares withheld for tax 867 shares at $10.01 of Recursion Pharmaceuticals8
- Feb 9, 2024Shares withheld for tax 1,892 shares at $10.09 of Recursion Pharmaceuticals9
- Feb 9, 2024Granted 49,768 shares of Recursion Pharmaceuticals9
- Feb 9, 2024Granted 6,040 shares of Recursion Pharmaceuticals9
- Jun 1, 2023Granted 190,713 shares of Recursion Pharmaceuticals10
- Oct 5, 2021Sold 1,289 shares at $32.06 of Prelude Therapeutics Inc6
- Oct 5, 2021Sold 7,803 shares at $31.30 of Prelude Therapeutics Inc6
- Oct 5, 2021Sold 5,908 shares at $30.26 of Prelude Therapeutics Inc6
- Oct 5, 2021Exercised options 15,000 shares at $1.89 of Prelude Therapeutics Inc6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARAdvaxis, Chief Medical Officer
- 5
- 6
- 7SEC EDGARForm 4 filed Aug 19, 2024
- 8SEC EDGARForm 4 filed May 17, 2024
- 9SEC EDGARForm 4 filed Feb 13, 2024
- 10SEC EDGARForm 4 filed Jun 7, 2023